Novo Nordisk Income Statement
View: Annual | Quarterly
| Dec 08 | Dec 07 | Dec 06 | |
|---|---|---|---|
| Revenue | 8,627.7 | 8,257.4 | 6,853.6 |
| Cost of Goods Sold | 1,914.6 | 1,933.1 | 1,695.6 |
| Gross Profit | 6,713.1 | 6,324.3 | 5,158.1 |
| Gross Profit Margin | 77.8% | 76.6% | 75.3% |
| SG&A Expense | 2,935.9 | 2,937.1 | 2,475.7 |
| Depreciation & Amortization | 462.5 | 593.6 | 378.9 |
| Operating Income | 2,533.4 | 2,265.8 | 1,731.9 |
| Operating Margin | 29.4% | 27.4% | 25.3% |
| Nonoperating Income | (23.5) | 243.4 | (46.0) |
| Nonoperating Expenses | 84.5 | -- | -- |
| Income Before Taxes | 2,404.4 | 2,165.7 | 1,621.1 |
| Income Taxes | 577.7 | 483.4 | 479.8 |
| Net Income After Taxes | 1,826.8 | 1,682.2 | 1,141.4 |
| Continuing Operations | 1,826.8 | 1,682.2 | 1,141.4 |
| Discontinued Operations | -- | -- | -- |
| Total Operations | 1,826.8 | 1,682.2 | 1,141.4 |
| Total Net Income | 1,826.8 | 1,682.2 | 1,141.4 |
| Net Profit Margin | 21.2% | 20.4% | 16.7% |
| Diluted EPS from Total Net Income ($) | 2.94 | 2.64 | 1.77 |
| Dividends per Share | 0.60 | 0.99 | 0.75 |
© 2009 Morningstar, Inc. Financial Data provided by
